Discover Sagimet Biosciences’ latest innovations in FASN inhibition for MASH and acne. Learn about new clinical trial data and market opportunities.

Get the latest on Avidity Biosciences' late-stage RNA drug pipeline, upcoming FDA filings, and market opportunities for rare muscle diseases.